Glatzel Markus, Rogivue Colette, Ghani Azra, Streffer Johannes R, Amsler Lorenz, Aguzzi Adriano
Institute of Neuropathology and National Reference Center for Prion Diseases, Schmelzbergstrasse 12, CH-8091 Zurich, Switzerland.
Lancet. 2002 Jul 13;360(9327):139-41. doi: 10.1016/S0140-6736(02)09384-4.
The incidence of Creutzfeldt-Jakob disease (CJD) in Switzerland increased two-fold in 2001, and figures from the first quarter of 2002 indicate that it continues to rise. Neither age at onset nor duration of disease were different from previous years. Genetic analysis of the 27 reported cases revealed only one disease-associated mutation in the prion gene. None of the recognised risk factors for acquired CJD were reported on the official notification forms. Glycotype profiling, histopathology, and immunohistochemistry indicate that none of the cases fulfilled the definition of variant CJD, which is thought to be caused by bovine prions. Several scenarios could account for the increase in CJD, including improved reporting, iatrogenic transmission, and transmission of a prion zoonosis.
2001年,瑞士克雅氏病(CJD)的发病率增长了两倍,2002年第一季度的数据表明其仍在上升。发病年龄和病程与往年并无差异。对27例报告病例进行的基因分析显示,朊病毒基因中仅发现一个与疾病相关的突变。官方报告表格中未提及任何已确认的获得性克雅氏病风险因素。糖型分析、组织病理学和免疫组织化学表明,这些病例均不符合变异型克雅氏病的定义,后者被认为是由牛朊病毒引起的。克雅氏病发病率上升可能有多种原因,包括报告改善、医源性传播以及朊病毒人畜共患病传播。